Catalog Number UNKPULSERIDER |
Device Problem
Break (1069)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Type
malfunction
|
Manufacturer Narrative
|
Product complaint #: (b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.Information regarding patient weight, height, medical history, race, and ethnicity was not reported.This device report is being submitted late due to incomplete complaint event information captured via the intake process cerenovus manufacturer's report numbers: 3008680601-2020-00002, 3008680601-2020-00003, 3008680601-2020-00004, 3008680601-2020-00005, 3008680601-2020-00006, 3008680601-2020-00007, 3008680601-2020-00008, 3008680601-2020-00011 are related to the same incident.
|
|
Event Description
|
This complaint is from a literature source.As reported in the literature publication entitled, ¿early postmarket results with pulserider for treatment of wide-necked intracranial aneurysms: a multicenter experience¿ (pmid:31703202) in the 1 case of a patient-treatment with intracranial aneurysm, who was treated with pulserider, with unsuccessful deployment, the device was delivered but had to be withdrawn due to coil herniation, and the aneurysm was treated with y stent-assisted coil embolization.Objective: traditionally, stent-assisted coiling and balloon remodeling have been the primary endovascular treatments for wide-necked intracranial aneurysms with complex morphologies.Pulserider is an aneurysm neck reconstruction device that provides parent vessel protection for aneurysm coiling.The objective of this study was to report early postmarket results with the pulserider device.Methods: this study was a prospective registry of patients treated with pulserider at 13 american neuro interventional centers following fda approval of this device.Data collected included clinical presentation, aneurysm characteristics, treatment details, and perioperative events.Follow-up data included degree of aneurysm occlusion and delayed (> 30 days after the procedure) complications.
|
|
Search Alerts/Recalls
|
|